LKL-Strategi Buy on Dip/PullbackKaunter dalam sektor healthcare ini sedang dalam fasa uptrend, dan mendapat tempias yang positif dalam fasa Covid 19.
Dari segi FA tidak berapa bagus tapi sesuai untuk short term trading sebab kaunter tengah hit.
Boleh monitor untuk startegi buy on dip dalam jangkaan tarikh 12-13 Mei 2020.
Support: 0.370
Resistance 1: 0.405
Resistance 2: 0.425 (52 weeks high)
Resistance 3: 0.445 (kalau berjaya capai akan jadi new 52 week high dan all time high)
Healthcare
LYC-Kaunter Sektor Healthcare..Kemungkinan Rebound?Dari segi FA memang tak bagus..hanya sesuai untuk short term trade..
P/E Ratio: -
ROE (%): -36.83
Dari segi TA, kaunter sedang uptrend dan berada di atas MA20 (short term), MA50 (medium term) dan MA200 (long term)..krisis Covid-19 berikan anjakan positif kepada kaunter ini..daripada price movement, kaunter sedang pullback dan berkemungkinan akan lakukan rebound..boleh gunakan strategi Buy on Dip (BOD)..
Support: 0.325
Resistance 1: 0.350
Resistance 2: 0.370
Resistance 3: 0.405 (52 weeks high)
1Life Healthcare $ONEM$ONEM was very close to break the pivot resistance today since going public. The volume is well above the average. RSI broke the down trendline.
If you find my charts useful, please just leave me "Like"
thx
Arena Pharmaceuticals $ARNA cup w handle$ARNA failed to break the resistance of cup w handle today.
If you find my charts useful, please just leave me a "Like"
thx
$ATHX can rise in the next daysContextual immersion trading strategy idea.
Athersys is a biotechnology company, focuses on the research and development activities in the field of regenerative medicine.
The share price rose after good earnings. I see some preconditions the share price will continue growing.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $2,85;
stop-loss — $2,57.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$NBSE can rise in the next daysContextual immersion trading strategy idea.
NeuBase Therapeutics is a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes.
The demand for shares of the company looks higher than the supply.
These and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $8,13;
stop-loss — $7,60.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
$SIBN can rise in the next daysContextual immersion trading strategy idea.
SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally.
The share price rose after good earnings. I see some preconditions the share price will continue growing.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $16,93;
stop-loss — $15,14.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Sorrento Therapeutics $SRNEUnconfirmed double bottom for $SRNE. It needs to break $2.66 for target price
If you find my charts useful, please just "Like"
VBIV break out [$1.50 target]VBIV is breaking out of a symmetrical triangle on 15min within a much larger ascending triangle on 4hr which may be a continuation pattern off of the local price bottom. I expect to see $1.50 within next 3 trading days.
$IFRX can rise in the next daysContextual immersion trading strategy idea.
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in the United States and Europe.
The share price rose after good earnings. I see some preconditions the share price will continue growing.
The demand for shares of the company still looks higher than the supply.
These and other conditions can cause a rise in the share price in the next days.
So I opened a long position from $7,22;
stop-loss — $6,73.
Information about take-profits will be later.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!